NCT06958978

Brief Summary

This prospective study aims to evaluate the safety and effectiveness of Quantum, a fully internal bipolar radiofrequency probe, for the treatment of prominent skin laxity, providing patients with a more toned and youthful appearance, in patients undergoing High-Definition (HD) Liposculpture. The main questions this study seeks to answer are:

  • Does Quantum reduce skin laxity in patients undergoing HD Liposculpture?
  • Is the effectiveness in skin laxity reduction influenced by demographical factors, including age, gender, and phototype? The participants will be adult patients (between 18-60 years) undergoing HD Liposculpture, with any measurable degree of skin laxity. The participants can not be pregnant, have history of scaring/healing problems, autoimmune diseases, severe dermatological conditions, have metal implants, be obese, or have important comorbidities.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
0mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Feb 2024Jun 2026

Study Start

First participant enrolled

February 1, 2024

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 2, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 6, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

May 6, 2025

Status Verified

April 1, 2025

Enrollment Period

1.8 years

First QC Date

February 2, 2025

Last Update Submit

April 27, 2025

Conditions

Keywords

QuantumQuantum RFElastometerBody contouringLiposuctionLiposculptureHigh Definition Liposculpture

Outcome Measures

Primary Outcomes (3)

  • Skin elasticity

    Objectively calculate using Elastometer the difference in the skin elasticity measures pre Quantum use (but after liposculpture procedure), immediate after Quantum use, and in the postoperative follow up on the 1st, 3rd and 6th month.

    6 months

  • Skin Viscoelasticity

    Objectively calculate using Elastometer the difference in the skin viscoelasticity measures pre Quantum use (but after liposculpture procedure), immediate after Quantum use, and in the postoperative follow up on 1st, 3rd and 6th month

    6 months

  • Skin retraction time

    Objectively calculate using Elastometer the difference in the retraction time measures pre Quantum use (but after liposculpture procedure), immediate after Quantum use, and in the postoperative follow up on 1st, 3rd and 6th month

    6 months

Secondary Outcomes (1)

  • Patient satisfaction

    6 months

Study Arms (1)

Quantum RF

EXPERIMENTAL

Right after the Liposuction procedure is completed, introduce the Quantum RF probe through the incision ports used for the liposuction. Using an imaginary grid with 1x1 cm pattern, apply assuring even distribution the Quantum RF (energy 15 J, pulse mode 3.0 pps) in the anatomical area. Maintain a uniform pace and energy level across the grid, covering both superficial and deep layers, to avoid hotspots and ensure consistent results.

Device: Quantum RF

Interventions

Patented handpiece device designed for skin rejuvenation and tightening through intraoperative subdermal Radiofrequency treatment.

Quantum RF

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients undergoing body contouring procedures (liposuction or liposculpture), either individually or combined with a maximum of two other major aesthetic procedures involving face, breast, or dermolipectomy.
  • Healthy patients without underlying comorbidities (classified as ASA≤II)

You may not qualify if:

  • Pregnant patients, patients planning to get pregnant, or in breastfeeding stage
  • Past medical history of any collagen disease or autoimmune conditions, including lupus, scleroderma, connective tissue disorders, rheumatoid arthritis, or multiple sclerosis.
  • Past medical history of skin disease including active skin infections, dermatitis, or history of keloid formation.
  • Patient with any metal implants or pacemakers
  • BMI ≥ 32 kg/m2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dhara clinic

Bogotá, DC, Colombia

RECRUITING

Related Publications (3)

  • Ibrahiem SMS. Aesthetic Nonexcisional Arm Contouring. Aesthet Surg J. 2022 Jun 20;42(7):NP463-NP473. doi: 10.1093/asj/sjac031.

    PMID: 35170726BACKGROUND
  • Chia CT, Theodorou SJ, Hoyos AE, Pitman GH. Radiofrequency-Assisted Liposuction Compared with Aggressive Superficial, Subdermal Liposuction of the Arms: A Bilateral Quantitative Comparison. Plast Reconstr Surg Glob Open. 2015 Aug 10;3(7):e459. doi: 10.1097/GOX.0000000000000429. eCollection 2015 Jul.

    PMID: 26301148BACKGROUND
  • Cala Uribe LC, Perez Pachon ME, Babaitis R, Zannin Ferrero A, Aljure Diaz MF. Variable Energy and Ultrasound-based Liposculpture of the Arms: Multicenter and Multidevice Study. Plast Reconstr Surg Glob Open. 2024 Mar 19;12(3):e5649. doi: 10.1097/GOX.0000000000005649. eCollection 2024 Mar.

    PMID: 38948160BACKGROUND

MeSH Terms

Conditions

Cutis Laxa

Condition Hierarchy (Ancestors)

Skin Diseases, GeneticGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Central Study Contacts

Alfredo Hoyos, Plastic Surgeon

CONTACT

Mauricio Perez, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All patients will receive Quantum Radiofrequency device as intervention in the anatomical areas were the skin laxity requires treatment. The skin laxity variables will be collected for all the areas at baseline (after liposculpture), immediate after Quantum, and during follow up months 1, 3, and 6.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Plastic Surgeon

Study Record Dates

First Submitted

February 2, 2025

First Posted

May 6, 2025

Study Start

February 1, 2024

Primary Completion

December 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

May 6, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Depending upon reasonable request

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
After results publication in scientific manuscript
Access Criteria
Request to the main author, stating the aims of the request, and the use the data will be given

Locations